Dr. Priyom Bose

How do common painkillers drive stronger E. coli resistance?

Research shows that non-antibiotic medications like ibuprofen can enhance E. coli mutations, raising concerns about antimicrobial resistance in older adults.

Omega-3 supplements lower heart rate in male athletes

Six weeks of omega-3 supplementation increases the omega-3 index and lowers heart rate in athletes, yet shows no performance advantage in endurance trials.

Eating more animal protein may slightly lower cancer mortality

Investigating protein intake, the study shows no mortality risk from animal or plant sources, with animal protein linked to modest cancer protection.

Climate variability may speed up the spread of vector-borne diseases

The study reveals that climate variability affects mosquito-borne disease risks, emphasizing the need for improved surveillance and public health strategies.

Why a common pesticide may alter brain growth in school-age children

Evidence review questions ketamine’s role in chronic pain treatment

A Cochrane review assessed ketamine and other NMDA receptor antagonists for chronic non-cancer pain. The evidence was low to very low certainty, showing no clear pain relief and potential adverse effects with intravenous ketamine.

How shifting landscapes drive new bird flu threats across Asia

Landscape changes across the East Asian–Australasian Flyway have reshaped waterfowl migration, increasing interactions with poultry. This shift amplified cross-species viral transmission and raised the risk of avian influenza virus reassortment and diversification.

Could chlorophyll become the next antidiabetic therapy?

Research highlights chlorophyll's role in blood sugar regulation and insulin mimicry, though safety risks and lack of human trials warrant caution.

New strategies to tackle resistant foodborne pathogens

Innovative approaches in food and beverage analysis are transforming pathogen detection and control, emphasizing the role of natural compounds and sequencing.

Heated herbal product delivers nicotine with fewer toxins

Research on the iSENZIA™ system shows it provides nicotine with significantly lower harmful chemicals, highlighting its tobacco harm reduction potential.